Application 125249
- Type
- BLA
- Sponsor
- REGENERON PHARMACEUTICALS
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ARCALYST | RILONACEPT | VIAL; SINGLE-USE | 220MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 61755-001 | Arcalyst | rilonacept | Regeneron Pharmaceuticals, Inc. | BLA | Current |
| 61755-001 | Arcalyst | rilonacept | Regeneron Pharmaceuticals, Inc. | BLA | Current |
| 61755-001 | Arcalyst | rilonacept | Regeneron Pharmaceuticals, Inc. | BLA | Current |
| 61755-001 | Arcalyst | rilonacept | Regeneron Pharmaceuticals, Inc. | BLA | Current |
| 61755-001 | Arcalyst | rilonacept | Regeneron Pharmaceuticals, Inc. | BLA | Current |
| 73604-914 | Arcalyst | rilonacept | Kiniksa Pharmaceuticals (UK), Ltd. | BLA | Current |
| 73604-914 | Arcalyst | rilonacept | Kiniksa Pharmaceuticals (UK), Ltd. | BLA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 85335 | SUPPL | 2026-03-12 |
| 85334 | SUPPL | 2026-03-12 |
| 81541 | SUPPL | 2025-03-12 |
| 66823 | SUPPL | 2021-03-22 |
| 66812 | SUPPL | 2021-03-19 |
| 65672 | SUPPL | 2020-12-22 |
| 65628 | SUPPL | 2020-12-21 |
| 64097 | SUPPL | 2020-07-27 |
| 64090 | SUPPL | 2020-07-24 |
| 43311 | ORIG | 2008-05-02 |
| 31869 | ORIG | 2008-04-09 |
| 39876 | ORIG | 2008-03-11 |